| NEOGENOMICS INC. |
| USA |
| Gesundheit |
| US64049M2098 / 120159 |
| NG9 (Frankfurt) / NEO (NASDAQ) |
| FRA:NG9, ETR:NG9, NG9:GR, NASDAQ:NEO |
| - |
| https://www.neogenomics.c.. |
|
NeoGenomics, Inc. is a cancer diagnostics company focused on oncology testing and information services. The company provides a broad menu of laboratory solutions across the cancer care continuum, including molecular testing, next-generation sequencin..
>Volltext.. |
| 2108.16 Mio. EUR |
| 2372.91 Mio. EUR |
| 680.79 Mio. EUR |
| 10.32 Mio. EUR |
| -46.09 Mio. EUR |
| -0.36 EUR |
| 398.34 Mio. EUR |
| 129.3 Mio. EUR |
| 19.59 Mio. EUR |
| 1.37 |
| 14.69% |
| 48.57% |
| - |
| - |
| - |
| - |
| NEOGENOMICS |
| 06.10.26 |